Circ Heart Fail

1. VERMA A, Fonarow GC, Heidenreich P, Allen LA, et al
   Get With The Guidelines-Heart Failure Hospital Participation and Its Association With Guideline-Directed Medical Therapy and Outcomes.
   Circ Heart Fail. 2026 Sep 2:e014414. doi: 10.1161/CIRCHEARTFAILURE.126.014414.
   

   >> Share

   
   
2. BROWNELL NK, Inkelas M, Chen L, Leng M, et al
   Healthcare System Resilience and Adaptation: A 6-Year Analysis of Heart Failure Care in the Veterans Affairs System.
   Circ Heart Fail. 2026 Aug 31:e014478. doi: 10.1161/CIRCHEARTFAILURE.126.014478.
   

   >> Share

   
   
3. JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al
   Electronic Nudges to Increase Influenza Vaccination Uptake in Young and Middle-Aged Patients with Heart Failure: A Prespecified Analysis of the NUDGE-FLU-CHRONIC Trial.
   Circ Heart Fail. 2026 Aug 29. doi: 10.1161/CIRCHEARTFAILURE.126.014891.
   

   >> Share

   
   

   
   Circulation

4. GUPTA R
   Multimodal Collaborative Care for Heart Failure in Resource-Limited Settings.
   Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082774.
   

   >> Share

   
   
5. KITKO LA
   Advancing the Science of Nurse-Led Collaborative Care in Heart Failure.
   Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082775.
   

   >> Share

   
   
6. JEEMON P, Ganapathi S, Anikkady N, Ismail S, et al
   Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India.
   Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082490.
   

   >> Share

   
   
7. JANUZZI JL JR, Rosenmeier JB, Ely Pizzato P, Quintana-Hayashi MP, et al
   Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.
   Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082763.
   

   >> Share

   
   

   
   Clin Cardiol

8. BERRY NC, Sheu YS, Chesbrough K, Clayton Bishop R, et al
   Comparison of Guideline-Directed Medical Therapy in Black versus White Patients With Heart Failure With Reduced Ejection Fraction in a Large, Integrated Health Care System.
   Clin Cardiol. 2026;49:e70452.
   

   >> Share

   
   

   
   Eur Heart J

9. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
   High-dose vs. standard-dose influenza vaccine in heart failure: the FLUNITY-HD trial.
   Eur Heart J. 2026 Aug 29:ehag709. doi: 10.1093.
   

   >> Share

   
   
10. PACKER M, Burkhoff D, Borlaug BA
    Adipose tissue-dependent, left ventricle-independent left atrial myopathy is a primary driver of heart failure with preserved ejection fraction: a hypothesis.
    Eur Heart J. 2026 Aug 30:ehag735. doi: 10.1093.
    

    >> Share

    
    
11. PEDICINO D, Volpe M
    Weekly Journal Scan: Simplifying guideline-directed medical therapy with a once-daily polypill improves treatment implementation and short-term outcomes in heart failure with reduced ejection fraction.
    Eur Heart J. 2026 Sep 3:ehag683. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Heart Fail

12. BAVENDIEK U, Liu X, Berliner D, Thomas NH, et al
    Efficacy of digitoxin over time in patients with heart failure and reduced ejection fraction: further analysis of DIGIT-HF.
    Eur J Heart Fail. 2026 Aug 29:xuag275. doi: 10.1093.
    

    >> Share

    
    
13. BOETTGER P, Grosshennig A, Stork S, Berliner D, et al
    Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States.
    Eur J Heart Fail. 2026 Aug 29:xuag270. doi: 10.1093.
    

    >> Share

    
    
14. KJELDSEN SE, Wachtell K, Devereux RB
    Blood pressure control and outcomes in heart failure patients with preserved ejection fraction: an individual participant data meta-analysis of four major trials.
    Eur J Heart Fail. 2026 Aug 30:xuag269. doi: 10.1093.
    

    >> Share

    
    
15. MAJOOR S, van der Meer P, Grote Beverborg N
    Dense but slow: bone remodelling in iron deficiency and heart failure.
    Eur J Heart Fail. 2026 Aug 31:xuag235. doi: 10.1093.
    

    >> Share

    
    
16. AMIR Y, Shaul A, Koren O, Merav L, et al
    Diurnal variation in left atrial pressure in ambulatory patients with chronic heart failure.
    Eur J Heart Fail. 2026 Aug 31:xuag280. doi: 10.1093.
    

    >> Share

    
    
17. 
    Correction to: Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials.
    Eur J Heart Fail. 2026 Aug 31:xuag248. doi: 10.1093.
    

    >> Share

    
    
18. KOECKERLING D, Reddy RK, Guivala SJ, Woodhead T, et al
    Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis.
    Eur J Heart Fail. 2026 Sep 1:xuag283. doi: 10.1093.
    

    >> Share

    
    
19. FERRANNINI G, Pol T, Ljungman C, Dahlstrom U, et al
    Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Regist
    Eur J Heart Fail. 2026 Sep 2:xuag249. doi: 10.1093.
    

    >> Share

    
    
20. ZONNEVELD LEEC, Martens P, Trullas JC, Damman K, et al
    Contemporary decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials.
    Eur J Heart Fail. 2026 Sep 2:xuag253. doi: 10.1093.
    

    >> Share

    
    
21. CHIMURA M, Docherty KF, Maggioni AP, Latini R, et al
    Renin-independent aldosterone production in heart failure with reduced ejection fraction: A post hoc analysis of the ALOFT trial.
    Eur J Heart Fail. 2026 Sep 3:xuag290. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Cardiol

22. ERICHSEN PA, Afzal M, Byrne C, Frary JMC, et al
    Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndrome.
    Int J Cardiol. 2026;464:134748.
    

    >> Share

    
    
23. JIMBA T
    From evidence to delivery: Optimising SGLT2 inhibitor therapy in heart failure.
    Int J Cardiol. 2026 Sep 1:134758. doi: 10.1016/j.ijcard.2026.134758.
    

    >> Share

    
    

    
    J Am Coll Cardiol

24. ANKER SD, Coats AJS, Lainscak M, von Haehling S, et al
    When Normal Is Not Normal: Hemoglobin in Heart Failure Revisited.
    J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07582.
    

    >> Share

    
    
25. NI W, Agewall S, Benson L, Breitner S, et al
    Cold Spells, Heat Waves, and Nonoptimal Air Temperature and Risk of Heart Failure Hospitalization in Sweden.
    J Am Coll Cardiol. 2026;88:1016-1029.
    

    >> Share

    
    

    
    J Card Fail

26. HELSETH R, Badrouchi S, Cruz-Solbes AS, Marti-Castellote P, et al
    Large Language Model Recommendations for Heart Failure Therapy.
    J Card Fail. 2026 Aug 29:S1071-9164(26)00493.
    

    >> Share

    
    
27. KHANNA S, McLellan N, Vasanthakumar S, Hwee Soh C, et al
    Epicardial Adipose Tissue Attenuation and Persistent Left Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction (RECOVER-EAT).
    J Card Fail. 2026 Sep 3:S1071-9164(26)00515.
    

    >> Share

    
    
28. LEGTENBERG S, Santos K, Beldhuis IE, Hartmann O, et al
    Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1-7), in Acute Heart Failure: Insights from the PUSH-AHF trial.
    J Card Fail. 2026 Sep 4:S1071-9164(26)00517.
    

    >> Share

    
    
29. VAN DER HOEF CCS, Maaten JMT, Meems LMG, Gorter TM, et al
    Body Composition in Heart Failure: A Phenotype-Informed Framework for Assessment and Management.
    J Card Fail. 2026 Sep 4:S1071-9164(26)00516.
    

    >> Share

    
    

    
    J Cardiol

30. KOBAYASHI M, Yoshioka E, Yamauchi T, Kawana F, et al
    Cheyne-Stokes respiration screening using cyclic variation in heart rate detected by Holter electrocardiogram.
    J Cardiol. 2026;88:205-212.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

31. POTEL KN, Shao A, McLaughlin N, Swingen C, et al
    Diastolic dysfunction persists 3 months after surgical revascularization in a large animal model of hibernating myocardium.
    J Thorac Cardiovasc Surg. 2026;172:575-581.
    

    >> Share

    
    

    
    Lancet

32. NIELSEN JC, Svendsen JH, Johansen JB, Larsen JM, et al
    Targeted left ventricular lead placement in biventricular pacing for heart failure: a national, multicentre, double-blind, randomised controlled trial in Denmark.
    Lancet. 2026 Aug 31:S0140-6736(26)01597-7. doi: 10.1016/S0140-6736(26)01597.
    

    >> Share

    
    
33. SLIWA K, Hahnle J, Stewart S, Allie S, et al
    Aetiology, management, and outcomes of acute heart failure in 17 African countries (THESUS-HF II): a prospective, multicentre, observational cohort study.
    Lancet. 2026 Aug 30:S0140-6736(26)01657-0. doi: 10.1016/S0140-6736(26)01657.
    

    >> Share

    
    
34. GAYE B, Ribeiro ALP, Marijon E
    Acute heart failure in Africa: new causes, unchanged outcomes.
    Lancet. 2026 Aug 30:S0140-6736(26)01754-X. doi: 10.1016/S0140-6736(26)01754.
    

    >> Share

    
    
35. SILVAIN J, Choi KH, Monguillon V, Kang D, et al
    Discontinuation of beta-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
    Lancet. 2026 Aug 30:S0140-6736(26)01426-1. doi: 10.1016/S0140-6736(26)01426.
    

    >> Share

    
    

    
    N Engl J Med

36. ZHANG H, Wang Q, Liang M, Chen X, et al
    Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
    N Engl J Med. 2026 Aug 30. doi: 10.1056/NEJMoa2609056.
    

    >> Share

    
    
37. HAUSLEITER J, Stocker TJ, Geisler T, Lurz P, et al
    Tricuspid-Valve Intervention in Heart Failure.
    N Engl J Med. 2026 Aug 30. doi: 10.1056/NEJMoa2606934.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share